The grant is made in honor and memory of Adam Michael Rosen, the Foundation’s namesake, who dedicated his short, yet impactful life to improving the world around him. Adam’s family created the Adam Michael Rosen Foundation to continue his legacy and ensure that families have the support they need as they navigate life after a cancer diagnosis.

“We are honored to make this donation in memory of our son and brother,” says Trisha Rosen, Adam’s mother and Director of the Adam Michael Rosen Foundation. “A cancer diagnosis is extremely difficult and consuming. If we can help another family or families in some small way, we will.”

“We are extremely excited and very honored to continue our partnership with the Adam Michael Rosen Foundation,” says Rick Sontag, President of Brain Tumor Network. “The Rosens know firsthand the impact that a brain tumor diagnosis has on a family, and their incredible generosity will help thousands of families receive the support and services they need to get the best care possible.”

For more information about the Adam Michael Rosen Foundation and their commitment to supporting brain tumor patients and their families, please visit https://amr-foundation.com/.

For more information about Brain Tumor Network or to donate, please visit https://www.braintumornetwork.org

Contacts:
Laura Hynes, Director of Operations
Brain Tumor Network
844-286-6110
lhynes@braintumornetwork.org

Rob Hubler, Public Relations Manager
Adam Michael Rosen Foundation
407-996-7656
rhubler@rosenhotels.com or publicrelations@rosenhotels.com.

###

About the Adam Michael Rosen Foundation:

The Adam Michael Rosen Foundation is a charitable organization based in Orlando, Florida, dedicated to helping fight cancer by supporting families and patients afflicted by the disease. The Foundation was established in memory of Adam Michael Rosen, whose legacy of compassion and support for others continues through the Foundation’s work. Its vision statement is “Hand in Hand through Hardship.”

About Brain Tumor Network:

Brain Tumor Network (BTN) is a nonprofit organization that provides personalized navigation services for brain tumor patients and their families. BTN’s co-navigation model combines nurse navigation with social work navigation to address both medical and psychosocial concerns, ensuring comprehensive support throughout the treatment journey.

The post Adam Michael Rosen Foundation Donates $100,000 to Support Brain Tumor Network appeared first on The Adam Michael Rosen Foundation.

More than 2,200 guests descended upon Rosen Shingle Creek this past Saturday night to attend the star-studded, ninth-year event in support of the true stars of the evening – 150 cancer warriors affected by pediatric cancer. The children ranged in age from 1 to 18 and were escorted on the runway, hand-in-hand, by local and national celebrities, to rousing applause.

National celebrities included Shark Tank star, Daymond John, Dancing with the Stars champion, Lindsay Arnold and Runway to Hope veteran and hometown favorite, Joey Fatone, all three of whom served as the evening’s hosts, along with Runway to Hope co-founder, businessman, and attorney, Mark NeJame and his wife, Josie.

“We are humbled and beyond excited for the outpouring of support Runway to Hope has received from Central Florida as we join together to help these courageous children and their families as they battle pediatric cancer, “said co-founder Josie NeJame. “This record setting year will allow us to help even more kids and for that we are so thankful.” she added.

Runway to Hope is honored to have been recognized 14 times in their nine-year existence as Central Florida’s Best Charity Event and has raised many millions for the cause of beating pediatric cancer.

For more information about Runway to Hope, please contact Runway to Hope’s Executive Director Laura Lockner at (407) 497-9121 or Laura@RunwaytoHope.org.

The post Record-Breaking $1.5 Million Raised at The Adam Michael Rosen Foundation Runway to Hope’s Spring Soiree appeared first on The Adam Michael Rosen Foundation.

ORLANDO — The University of Florida has received a $12 million gift from Orlando hotel magnate Harris Rosen and The Harris Rosen Foundation to advance innovative brain tumor immunotherapy research and care at UF Health and to launch an unprecedented partnership for the development of novel brain tumor treatments.

The Rosen gift is the cornerstone of a $100 million fundraising commitment to support the ReMission Alliance Against Brain Tumors, a groundbreaking, collaborative initiative led by UF that will unite world-leading neuro-oncology physicians and scientists in dynamic research and clinical trials.

The gift was announced Friday, Feb. 22, before the inaugural ReMission Summit for Brain Tumors at the Rosen Shingle Creek Hotel in Orlando. The UF-organized Summit brings together more than 100 experts in neuro-oncology, tumor immunology, genetics, artificial intelligence, neuroimaging and bioinformatics to form an elite research community focused on achieving transformative outcomes for patients with brain tumors over the next decade. The ReMission Summit also serves as the public forum for the debut of the ReMission Alliance, a multi-institutional research collaborative focused on the advancement of novel immunotherapies for adult and pediatric brain cancer.

“I am extremely grateful that Harris Rosen and his family share our vision to make a transformative impact on outcomes for patients with brain tumors,” said Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and director of the ReMission Alliance. “Their support of our research, patient care initiatives and the ReMission Alliance will allow us to leverage the power of the immune system to combat invasive brain cancers to dramatically improve the lives of brain tumor patients, here at UF and abroad.”

The ReMission Alliance’s work builds on the success and growth of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and collaborative research partnerships fostered over several years by Mitchell and his colleagues. Over the past five years, the center has undergone dramatic growth and established itself as a leader for brain tumor treatment and research. Along with William Friedman, M.D., co-director of the Preston A. Wells Jr. Center, Mitchell and his team will support several bold research projects and clinical trials coordinated with principal partners from among the world’s best research institutes and hospitals.

“Thanks to the generosity and support of Harris Rosen and his family, we are able to pursue research breakthroughs that result in real change,” UF President Kent Fuchs said. “I am confident that, together, we can advance the work necessary to provide extraordinary outcomes for patients suffering from malignant brain tumors and improve their survival rates and quality of life. The ReMission Alliance embodies UF’s commitment to the greater good.”

This work — to organize multidisciplinary, collaborative research efforts among groups of skilled researchers and physicians — resonated deeply with Harris Rosen. His son, Adam, who received care at UF Health, died in November after a prolonged fight with brain cancer. Harris was impressed by the UF Health clinical team’s professionalism, skill and commitment to making Adam and his family as comfortable as possible.

“It was obvious how dedicated they are to improving the quality of life for their patients,” Rosen said. “The team at UF is already doing extraordinary work, and the Alliance will enhance their progress and improve outcomes for patients well beyond Florida. A collaboration like this is difficult and lofty, but my family and I support this vision to rewrite the story of brain cancer.” The Rosen gift will bolster ongoing research efforts at UF Health and provide vital seed funding for the ReMission Alliance. The suite that houses the UF Health Neuromedicine practice at the UF Health Neuromedicine Hospital and the neuro-oncology laboratories within UF’s Evelyn F. and William L. McKnight Brain Institute will be named in honor of Adam Michael Rosen. This investment by the Rosen family adds considerably to the UF Health Cancer Center’s growing resources to combat deadly malignant diseases. Mitchell serves as co-leader of the UFHCC Cancer Therapeutics and Host Response, or CTHR, program.

“Programs like the CTHR bring researchers from numerous UF colleges, departments, centers and institutes together, working in tandem to advance the development of new cancer therapies for resistant cancers,” said Jonathan D. Licht, M.D., director of the UFHCC. “Initiatives at the Cancer Center have become a centerpiece of UF Health’s overall research portfolio, which includes approximately $200 million per year in NIH funding and totals $450 million in sponsored program expenditures.”

David Nelson, M.D., UF’s interim senior vice president for health affairs, added his appreciation for the Harris Rosen Foundation gift.

“This contribution to the groundbreaking work and collaboration that our team at UF Health is undertaking is a significant vote of confidence that our efforts will make a profound impact on the people and communities we serve,” Nelson said. “Our physicians and researchers are fueling scientific discovery while developing new, promising pathways for patient care. Through the collaboration that this gift catalyzes, our impact will be even greater.”

These transformative commitments demonstrate how UF, as one of just a handful of global comprehensive universities, is positioned to leverage its research expertise and academic excellence to create lasting impact in the health care field and address major societal challenges.

Harris Rosen is the founder, president and chief operating officer of Rosen Hotels & Resorts. His company owns eight hotels and resorts in Central Florida, including the 1,501-room, AAA Four Diamond Rosen Shingle Creek.

The post University of Florida and UF Health announce $12 million gift from Orlando business leader to launch brain tumor research initiative appeared first on The Adam Michael Rosen Foundation.